OPTI SARA-COV-2 RT-PCR
Report
- Report Number
- 3004102403-2021-00002
- Event Type
- Malfunction
- Date Received
- June 12, 2021
- Date of Event
- May 1, 2021
- Report Date
- June 12, 2021
- Manufacturer
- OPTI MEDICAL SYSTEMS, INC.
- Product Code
- QJR
- PMA / PMN Number
- EUA200215
- Removal / Correction Number
- Z-2310-2021
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
OPTI MEDICAL SYSTEMS SENT A NOTICE TO CUSTOMERS BASED ON DISCUSSIONS WITH FDA INDICATING THAT USERS OF OPTI SARS-COV-2 RT PCR TEST THAT A CENTRIFUGATION STEP IS NECESSARY TO PREVENT FALSE POSITIVIES WHEN USING OUR PCR TEST.
OF THE 21 POSITIVE SAMPLES CORRELATES 100% WITH PREVIOUS RESULTS. OUT OF 19 NEGATIVE PATIENT'S SAMPLES, 2 SAMPLES CAME OUT POSITIVES WITH HIGH CT VALUES (36.0 AND 41.84 RESPECTIVELY). AN EXPLANATION OF ONE OF THE DISCREPANCIES, THE ONE WITH THE HIGH CT VALUE COULD BE A CONTAMINATION ISSUE. THE DISCREPANCIES OBTAINED WHEN VALIDATING THIS ASSAY CAN DEPEND ON THE SENSITIVITY OF EACH METHODOLOGY, THE PLATFORM USED AND THE REAGENTS USED TO TEST THESE SAMPLES.
OF THE 21 POSITIVE SAMPLES CORRELATES 100% WITH PREVIOUS RESULTS. OUT OF 19 NEGATIVE PATIENT'S SAMPLES, 2 SAMPLES CAME OUT POSITIVES WITH HIGH CT VALUES (36.0 AND 41.84 RESPECTIVELY). AN EXPLANATION OF ONE OF THE DISCREPANCIES, THE ONE WITH THE HIGH CT VALUE COULD BE A CONTAMINATION ISSUE. THE DISCREPANCIES OBTAINED WHEN VALIDATING THIS ASSAY CAN DEPEND ON THE SENSITIVITY OF EACH METHODOLOGY, THE PLATFORM USED AND THE REAGENTS USED TO TEST THESE SAMPLES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 885203 | OPTI SARA-COV-2 RT-PCR | COVID 19 MOLECULAR DIAGNOSTIC TEST | QJR | OPTI MEDICAL SYSTEMS, INC. | 99-57003 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |